Axsome Therapeutics, Inc. · XETR:19X

Axsome Therapeutics, Inc. financial statements

Axsome Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue638.5M385.7M270.6M0
Cost of revenue5.20M
Gross profit-5.20M
Research and development183.3M187.1M97.9M57.9M58.1M70.2M53.6M23.5M20.0M21.2M
Selling, general and administrative570.6M411.4M323.1M159.3M66.6M28.9M
Operating income-166.8M-280.6M-231.8M-179.8M-124.7M-99.1M-67.2M-32.8M-27.2M-27.5M
Depreciation and amortization503.0K532.0K459.0K263.0K76.0K23.9K37.3K48.9K42.6K20.5K
EBITDA-166.3M-280.0M-231.4M-179.5M-124.6M-99.1M-67.2M-32.8M-27.1M-27.5M
Interest expense-15.9M-21.6M-20.0M-9.66M
Income before tax-183.7M-287.1M-238.3M-187.1M-130.4M
Income tax-530.0K85.0K960.0K0000000
Net income-183.2M-287.2M-239.2M-187.1M-130.4M-102.9M-68.3M-31.0M-28.9M-27.2M
Earnings per share, basic-3.68-5.99-5.27-4.60-3.47-2.77-2.01-1.15-1.27-1.42
Earnings per share, diluted-3.68-5.99-5.27-4.60-3.47-2.77-2.01-1.15-1.27-1.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents322.9M315.4M386.2M200.8M86.5M183.9M220.0M14.0M34.0M36.6M
Receivables224.5M142.0M94.8M37.7M
Inventory27.9M15.7M15.1M4.32M
Current assets589.0M485.1M504.3M245.6M86.5M184.0M220.4M15.2M35.3M38.0M
Property, plant and equipment562.0K584.0K846.0K722.0K283.8K52.6K30.6K51.8K68.1K100.7K
Goodwill12.0M12.0M12.0M10.3M
Total assets689.8M568.5M588.2M331.5M87.8M186.1M220.5M15.4M35.6M38.2M
Accounts payable65.5M72.0M40.7M38.6M13.1M13.5M10.9M3.69M3.44M4.08M
Current liabilities378.8M230.1M138.9M96.6M23.1M23.4M24.5M10.8M12.2M7.17M
Long-term debt117.7M180.7M178.1M94.3M49.1M48.3M17.3M3.62M6.66M9.47M
Total debt187.7M180.7M178.1M94.3M49.1M48.3M19.9M6.91M9.93M9.74M
Total liabilities601.5M511.5M397.3M221.9M72.2M72.3M41.8M14.4M18.8M16.6M
Shareholders' equity88.3M57.0M191.0M109.6M15.6M113.8M178.7M937.9K16.7M21.6M
Shares outstanding50.9M48.7M47.4M43.5M37.8M37.4M36.9M30.1M25.5M19.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-93.4M-128.4M-145.1M-116.5M-108.2M-78.5M-46.4M-30.1M-26.5M-21.3M
Capital spending-480.0K-270.0K-582.0K-702.0K-308.0K-45.9K-16.1K-32.7K-9.90K-104.6K
Free cash flow-93.9M-128.7M-145.7M-117.2M-108.5M-78.5M-46.4M-30.1M-26.5M-21.4M
Cash from investing-480.0K-270.0K-582.0K-53.7M-308.0K-45.9K-16.1K-32.7K-9.90K-104.6K
Cash from financing101.5M57.8M331.0M284.6M11.1M42.4M252.4M10.0M23.9M9.97M
Change in cash7.58M-70.8M185.4M114.4M-97.4M-36.1M206.0M-20.1M-2.60M-11.4M